Terapet Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 11

Terapet General Information

Description

Developer of an imaging technology of proton therapy designed to treat cancer, specializing in the development and manufacturing of innovative nuclear medicine imaging systems. The company's therapy administers a lesser dose to the healthy tissue surrounding the tumor since the protons stop at a certain depth inside the patient, delivering a high dose just before they stop, enabling medical doctors to monitor the delivered proton dose inside the patients during cancer treatment in three-dimensional and real-time at a reduced cost.

Contact Information

Website
www.terapet.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rue du Pré-Bouvier 7
  • Satigny
  • 1242 Geneva
  • Switzerland
+41 076
Primary Industry
Diagnostic Equipment
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Rue du Pré-Bouvier 7
  • Satigny
  • 1242 Geneva
  • Switzerland
+41 076

Terapet Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Terapet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Secondary Transaction - Private Completed Generating Revenue
16. Later Stage VC (Series A) 15-Mar-2024 Completed Generating Revenue
15. Grant 01-Mar-2024 Completed Generating Revenue
14. Grant 01-Nov-2023 Completed Generating Revenue
13. Grant 01-Nov-2023 Completed Generating Revenue
12. Accelerator/Incubator Completed Generating Revenue
11. Grant 01-Aug-2023 Completed Generating Revenue
10. Early Stage VC 01-Oct-2021 Completed Product In Beta Test
9. Grant 01-Feb-2021 $868K $1.97M Completed Product In Beta Test
8. Grant 29-Oct-2020 $10.9K $1.97M Completed Product In Beta Test
To view Terapet’s complete valuation and funding history, request access »

Terapet Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 2,703,944 $0.42 $0.42 1x $0.42 38.46%
Ordinary 8,815,788 $0.02 $0.02 1x $0.02 125.38%
To view Terapet’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Terapet Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Terapet Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026185202-A1 Gamma-ray detector unit Pending 04-Mar-2025
EP-4400161-A1 Quality assurance system for particle radiation therapy Active 12-Jan-2023
EP-4400161-B1 Quality assurance system for particle radiation therapy Active 12-Jan-2023
EP-4400161-C0 Quality assurance system for particle radiation therapy Active 12-Jan-2023
WO-2024149710-A1 Quality assurance system for particle radiation therapy Inactive 12-Jan-2023 A61N5/1075
To view Terapet’s complete patent history, request access »

Terapet Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Terapet Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
EFI Lake Geneva Ventures Venture Capital Minority
EUREKA Network Accelerator/Incubator
Korea Institute for Advancement of Technology Government Minority
Innosuisse Government
Efficient Frontier Investing Asset Manager Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Terapet FAQs

  • When was Terapet founded?

    Terapet was founded in 2019.

  • Where is Terapet headquartered?

    Terapet is headquartered in Geneva, Switzerland.

  • What is the size of Terapet?

    Terapet has 15 total employees.

  • What industry is Terapet in?

    Terapet’s primary industry is Diagnostic Equipment.

  • Is Terapet a private or public company?

    Terapet is a Private company.

  • What is Terapet’s current revenue?

    The current revenue for Terapet is .

  • How much funding has Terapet raised over time?

    Terapet has raised $5.53M.

  • Who are Terapet’s investors?

    EFI Lake Geneva Ventures, EUREKA Network, Korea Institute for Advancement of Technology, Innosuisse, and Efficient Frontier Investing are 5 of 11 investors who have invested in Terapet.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process